According to a different ovarian cancer study, apigenin inhibited the growth of ovarian cancer by down-regulating the expression of ER-mediated PI3K/AKT/mTOR, indicating that it may be used as a therapeutic agent to treat ovarian cancer as shown in Figure 12 [178]. This evidence concerns the gene MTOR and ovarian carcinoma.